Medication and Endurance Training: What Changes in Your Plan

Roughly one in three endurance athletes over 40 takes medication regularly — blood pressure drugs, statins, proton pump inhibitors, antihistamines. Almost none of them consider that these substances can change how training is controlled. A beta blocker turns a heart rate target into a meaningless number. A diuretic shifts fluid balance. A fluoroquinolone antibiotic can damage the Achilles tendon while the plan still calls for intervals. This article sorts the relevant drug classes by their impact on training, gives concrete numbers and describes what has to change in the plan.

Why medication is its own topic in sport

Training control rests on the assumption that heart rate, pace and perceived effort sit in a stable relationship with each other. Many drugs shift exactly that relationship. The same pace can produce a heart rate of 145 or of 118 under medication — at identical oxygen uptake. Anyone who then trains strictly by heart rate zones ends up either in the wrong intensity or in overtraining.

There is a second problem: approval studies for most drugs test efficacy and side effects at rest or under everyday load, not during three hours of endurance work with heat, dehydration and depleted glycogen stores. The interaction between drug and load is therefore often less well studied than the drug's own effect.

The most important rule up front: never stop or re-dose your own long-term medication on your own initiative. Almost all adjustments are training adjustments, not medication adjustments — and those run through your doctor.

The five classes that matter in training

• Beta blockers (bisoprolol, metoprolol, nebivolol): lower heart rate and maximal performance. Heart rate control becomes impossible, but training remains sensible and desirable.
• Diuretics (HCT, furosemide, indapamide): reduce plasma volume and raise the risk of dehydration and electrolyte loss. They are also on the doping list as masking agents — irrelevant in recreational sport, relevant in races with reporting obligations.
• Statins (atorvastatin, rosuvastatin, simvastatin): can cause muscle pain and elevated CK, rarely rhabdomyolysis. That directly affects exercise tolerance.
• Antibiotics: fluoroquinolones (ciprofloxacin, levofloxacin) carry a raised tendon rupture risk; tetracyclines and macrolides stress stomach and liver. With fever, training is off the table anyway.
• Painkillers and antihistamines: NSAIDs (ibuprofen, diclofenac) impair kidney perfusion and the gastric mucosa under load. First-generation antihistamines raise heart rate and reduce sweat production.

Not on this list but frequently underestimated: SSRI antidepressants, which can change sweating behaviour and blood sodium concentration, and proton pump inhibitors, which lower magnesium and vitamin B12 uptake over years. Neither is usually acutely problematic in daily training, but both explain the occasional inexplicable dip in performance.

Beta blockers: heart rate control stops working

Beta blockers block the beta-1 receptors in the heart and dampen both resting heart rate and maximal heart rate. At standard doses, maximal heart rate typically sits 20 to 30 beats lower than before, maximal oxygen uptake falls by five to ten percent, and heart rate rises much more slowly under load.

For training practice this means three things:

• Heart rate zones from the old days are invalid. Someone who previously had a threshold at 168 beats may now sit at 142 — or never reach it at all. The zones have to be re-determined, ideally through performance testing rather than a formula.
• Pace and perceived effort become the leading variables. RPE scale, breathing rate and the talk test are more reliable on beta blockers than any heart rate number. An easy run stays an easy run even if heart rate reads 118.
• Performance drops, the training stays worthwhile. Endurance training is explicitly recommended in hypertension and after cardiac events and improves prognosis as well as exercise capacity. Target times change, the training effect does not.

Nebivolol is an exception within the group: it dilates vessels more and lowers heart rate less strongly than classic beta blockers. Anyone switched to it often notices an unexpectedly higher training heart rate — no reason for concern, but a reason to check the zones again. The fundamentals are in the article Heart rate zones.

Diuretics, statins, antibiotics: the concrete risks

Diuretics act via the kidney and excrete more water and electrolytes. In heat and on long sessions this accumulates with sweat loss: two percent dehydration is reached faster on diuretics, performance already drops measurably at that point, and cramps appear earlier. In practice that means drinking more with sodium, no long sessions in the midday heat, and a deliberate eye on potassium and magnesium. Details on individual fluid intake are in the article Hydration when running.

Statins inhibit HMG-CoA reductase and thereby lower cholesterol synthesis — in muscle they also reduce coenzyme Q10 formation and affect mitochondrial function. This becomes clinically relevant in five to ten percent of users as muscle pain or weakness, usually symmetrical in thighs and upper arms, typically in the first weeks to months. CK is often normal. Dangerous but rare is rhabdomyolysis with dark urine, severe pain and CK values above ten times normal — then get medical assessment immediately and do not train through it.

For training: do not start a new statin at the same time as your hardest training week. Anyone who deliberately keeps load moderate for the first four to six weeks on a statin can attribute muscle pain clearly — otherwise it stays unclear whether the pulling comes from the drug or the training block.

Fluoroquinolones are the critical case. They raise the risk of tendinopathy and tendon rupture, particularly of the Achilles, with a peak frequency in the first two weeks after intake — and an elevated risk that remains raised for up to a year after therapy. The product information advises avoiding strenuous physical load during treatment and for several days afterwards. In practice: no intervals, no jumping, no long hill runs during that period, but easy movement in a pain-free range. What helps with tendon problems is in the article Achilles tendinopathy and running.

Painkillers: the mistake most often made

Ibuprofen before a marathon is widespread in recreational sport and from a medical standpoint one of the worst ideas going. NSAIDs inhibit prostaglandin synthesis — and prostaglandins are involved in regulating kidney perfusion. Under load, when up to 80 percent of cardiac output goes to muscle and the kidney is already barely supplied, that protective function disappears. The risk of acute kidney injury rises markedly, especially in heat, dehydration and with simultaneous diuretics or ACE inhibitors.

Add gastric mucosal damage, increased intestinal permeability — which worsens race-day gut problems instead of easing them — and impaired platelet function. The hoped-for effect of suppressing pain in order to run faster is not supported by evidence either; what is supported is only that injury signals get masked. More on this in Painkillers in endurance sport.

Paracetamol is not a harmless alternative either: it is metabolised in the liver, and the combination of long duration, heat and low glycogen availability increases hepatic load. For endurance sport the rule is: painkillers are not a training companion but an exception with a clear indication.

What this means for the training plan and heart rate zones

Anyone starting long-term medication should not simply let the plan run on. A three-step approach makes sense:

• Weeks 1 and 2: reduce load. Volume down to 60 to 70 percent of usual, no intervals, no races. The goal is not adaptation but observation — how do heart rate, sleep, muscles and digestion react.
• Weeks 3 and 4: re-determine zones. An easy reference run under stable conditions (same route, similar temperature) over four to six weeks shows whether the pace-heart-rate relationship has shifted. On beta blockers a talk test helps in addition: two sentences in a row is zone 2, single words are zone 4.
• From week 5: adjust the plan. Set goals realistically. If maximal heart rate has dropped by 25 beats, last year's marathon personal best is not a sensible target. New target times can be estimated from a test run, not from the old form curve.

One point that is often overlooked: medication also changes recovery. Statins, beta blockers and diuretics can lower HRV and affect sleep. If the form curve stagnates after a switch, the obvious reaction — train more — is the wrong one. How to weigh load and recovery properly is described in CTL, ATL and TSB.

Travel, time zones and medication timing

An underestimated factor is the timing of intake. Beta blockers taken in the morning dampen heart rate exactly in the window when most people train. Switching to an evening dose often makes a noticeable difference in training — but that belongs in consultation with the doctor, because some preparations are deliberately prescribed for the morning.

Diuretics are almost always taken in the morning to avoid nocturnal toilet trips. That collides with morning runs: anyone heading out directly after intake starts with a reduced plasma volume already. Two hours of separation and a glass of water before the run solve the problem in most cases.

When travelling across several time zones, intake time shifts with the daily rhythm. For short trips a shift of a few hours is unproblematic; beyond six hours' difference a consultation is worthwhile. How to plan training in that situation is in the article Training while travelling and in the piece on jetlag in endurance sport.

When you should not train

There are constellations where the answer is not "adjust the plan" but "pause":

• Fever. Above 38 degrees core temperature training is off limits. The risk of myocarditis outweighs any lost week.
• Fluoroquinolone therapy. During intake and for at least several days afterwards, no intense load, no jumping, no rapid changes of direction.
• New medication with known cardiovascular effects. In the first days dizziness, orthostasis and blood pressure drops can occur — especially when combining several blood pressure drugs.
• Muscle pain on a statin with dark urine. Get medical assessment immediately, suspend training until it is clarified.
• Unexplained chest pain, palpitations, unusual dyspnoea. With any new symptom under medication, the order is: clarify first, train second.

The most common mistake in this situation is not overtraining but the attempt to fight a drug effect with training. When a blood pressure drug suppresses heart rate, that cannot be "trained away" — it can only be interpreted correctly.

What Peakora can do — and what it cannot

Peakora is not a medical device and not medical advice. The plan adapts volume, intensity and recovery to the data you enter: availability, goals, races, perceived effort and the form curve from CTL, ATL and TSB. The engine does not recognise long-term medication by itself.

What you can do: log in your profile that you take medication regularly and note in the training log since when. Reduce the planned load manually in the first two weeks after a switch. And if heart rate at the same pace is suddenly 15 beats higher, that is a signal for the form curve — not a call for more training. The terms around load control are explained in the Peakora glossary, the fundamentals of marathon build-up on the marathon training page.

In the end one simple rule remains: medication changes the framework, not the principle. Endurance training still works — just with different numbers on the display.

Frequently asked questions about medication in endurance sport